Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD)
This study has been completed.
Sponsor:
Dr. Falk Pharma GmbH
Information provided by:
Dr. Falk Pharma GmbH
ClinicalTrials.gov Identifier:
NCT00300118
First received: March 7, 2006
Last updated: February 2, 2011
Last verified: February 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | May 2008 |
| Primary Completion Date: | May 2008 (Final data collection date for primary outcome measure) |